CTXR: Citius Pharmaceuticals Inc. Amount of Cash per Share

Corporate emblem and logo of Citius Pharmaceuticals Inc. (CTXR)

Citius Pharmaceuticals attracts experts with its ethical approach to developing breakthrough oncology drugs. Free cash flow per share clearly demonstrates the business's liquidity, where 0.63 expresses the metric's value today. The brand is valued by critical care specialists for its effective fight against infections. The company is expanding its influence by securing exclusive FDA approvals to minimize price competition when launching new products.

CTXR: citiuspharma.com Cash per Share 07/04/2022 - 11/20/2026

Analytical breakdowns for Citius Pharmaceuticals

- cash position and cash flow details:
Summary company analysis:CTXR, Citius Pharmaceuticals Inc.
Original product of Citius Pharmaceuticals

Professional selection of resilient assets begins with an analysis of the liquid reserve. This metric is calculated by dividing total cash holdings by the number of shares outstanding. By analyzing cash per share, an investor determines the real monetary value of their ownership stake. For Citius Pharmaceuticals (CTXR), current liquidity reserves remain sufficient. This is critically important for financing the implementation of antibacterial drugs in US clinics and covering R&D expenses.